Point72 Asia (Singapore)’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,004	Closed	-$56.1K	–	1350
2024 Q1	$56.1K	Buy	4,004 +3,784	+1,720%	+$53K	0.01%	775
2023 Q4	$1.87K	Buy	+220	New	+$1.87K	﹤0.01%	563